[THE INVESTOR] The UN-operated Green Climate Fund has decided to inject US$ 256.6 million in climate change projects in nine developing countries, the Ministry of Strategy and Finance said July 1. The decision was made during the 13th board meeting of the GCF, held at its headquarters in Songdo, Incheon, from June 28 to 30. The newly approved projects include solar energy development program in Chile, projects to make coastal communities in Vietnam more resilient to climate change impacts and su

Celltrion’s sales and profit should normalize from 2Q16. Looking at 2H16, we suggest that investors focus on: 1) the start of supply (from 3Q16) of Celltrion Healthcare’s Remsima to Pfizer; 2) expected approvals for Celtrion’s Rituxan and Herceptin biosimilars; 3) a planned IPO for Celltrion Healthcare; and 4) new disclosure rules for short-selling balances.2Q16 preview: Earnings normalizing; COGS-to-sales ratio and SG&A-to-sales ratio stabilizingCeltrion chairmanSeo Jung-jinWe expect Celltrion